| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Wettig Thane | CEO, Director | C/O FIBROGEN, INC., 350 BAY STREET, SUITE 100, #6009, SAN FRANCISCO | /s/ John Alden, Attorney-in-Fact | 17 Nov 2025 | 0001815638 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | FGEN | Common Stock | Purchase | $9,180 | +1,000 | +4.7% | $9.18 | 22,239 | 13 Nov 2025 | Direct | |
| transaction | FGEN | Common Stock | Purchase | $24,570 | +2,700 | +12% | $9.10 | 24,939 | 17 Nov 2025 | Direct | |
| holding | FGEN | Common Stock | 40 | 13 Nov 2025 | By spouse |